Ardelyx’s highly anticipated tenapanor, indicated to treat hyperphosphatemia in dialysis patients, nearing market’s doorstep

Tenapanor is an inhibitor of sodium/hydrogen exchanger isoform 3 found in the kidneys, which acts to regulate sodium absorption and secretion in the body under normal physiological conditions.